IMPAVIDO™ (MILTEFOSINE) FOR ANNERGIC DIFFUSE CUTANEOUS LEISHMANIASIS, A RARE AND INTRACTABLE DISEASE

被引：0
|
作者：
Hueb, M. [1 ]
Oliveira, T. F. [1 ]
Grigoli, E. [1 ]
Viana, T. R. [1 ]
Proenca, W. B. [1 ]
Damin, B. C. [1 ]
Fonseca-Jr, E. A. [1 ]
Carvalho, A. P. [1 ]
Cavalcante, L. R. S. [1 ]
Reis, P., V [1 ]
机构：
[1] Univ Fed Mato Grosso, Hosp Univ Julio Muller, Cuiaba, MG, Brazil
来源：
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2019年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P178
引用
收藏
页码：S154 / S154
页数：1
相关论文
共 50 条
  • [41] Case Report: Erysipeloid Cutaneous Leishmaniasis Treated with Oral Miltefosine
    Parajuli, Niraj
    Adhikary, Sabeena
    Karki, Anupama
    Tiwari, Sumida
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 104 (02): : 643 - 645
  • [42] DIFFUSE CUTANEOUS LEISHMANIASIS - DISEASE DUE TO AN IMMUNOLOGICAL DEFECT OF HOST
    CONVIT, J
    RONDON, AJ
    PINARDI, ME
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1972, 66 (04) : 603 - +
  • [43] Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis
    Peralta, Ma. Florencia
    Usseglio, Nadina A.
    Bracamonte, Ma. Estefania
    Guzman, Ma. Laura
    Olivera, Ma. Eugenia
    Marco, J. Diego
    Barroso, Paola A.
    Carrer, Dolores C.
    [J]. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2022, 12 (01) : 180 - 196
  • [44] Dynamics of Parasite Clearance in Cutaneous Leishmaniasis Patients Treated with Miltefosine
    Dorlo, Thomas P. C.
    van Thiel, Pieter P. A. M.
    Schoone, Gerard J.
    Stienstra, Ymkje
    van Vugt, Michele
    Beijnen, Jos H.
    de Vries, Peter J.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (12)
  • [45] Overcoming the Challenge; In Vivo Efficacy of Miltefosine for Chronic Cutaneous Leishmaniasis
    Varol Tunalı
    Mehmet Harman
    İbrahim Çavuş
    Cumhur Gündüz
    Ahmet Özbilgin
    Nevin Turgay
    [J]. Acta Parasitologica, 2021, 66 : 354 - 360
  • [46] Noninferiority of Miltefosine Versus Meglumine Antimoniate for Cutaneous Leishmaniasis in Children
    Consuelo Rubiano, Luisa
    Consuelo Miranda, Maria
    Muvdi Arenas, Sandra
    Mery Montero, Luz
    Rodriguez-Barraquer, Isabel
    Garcerant, Daniel
    Prager, Martin
    Osorio, Lyda
    Ximena Rojas, Maria
    Perez, Mauricio
    Santiago Nicholls, Ruben
    Gore Saravia, Nancy
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (04): : 684 - 692
  • [47] Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis
    Ma. Florencia Peralta
    Nadina A. Usseglio
    Ma. Estefanía Bracamonte
    Ma. Laura Guzmán
    Ma. Eugenia Olivera
    J. Diego Marco
    Paola A. Barroso
    Dolores C. Carrer
    [J]. Drug Delivery and Translational Research, 2022, 12 : 180 - 196
  • [48] Pharmacokinetics of miltefosine in patients treated for old world cutaneous leishmaniasis
    Dorlo, T. P. C.
    Hillebrand, M. J. X.
    Rosing, H.
    Eggelte, T. A.
    Van Thiel, P. P. A. M.
    Van Vugt, M.
    Faber, W. R.
    De Vries, P. J.
    Beijnen, J. H.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2007, 12 : 93 - 93
  • [49] In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis: Follow-Up
    Coelho, Adriano C.
    Trinconi, Cristiana T.
    Costa, Carlos H. N.
    Uliana, Silvia R. B.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2016, 10 (07):
  • [50] Diffuse cutaneous leishmaniasis in coexistence with leprosy
    Patrao, Ninon A. R.
    Bhat, Ramesh M.
    Dandekeri, Sukumar
    Kambil, Srinath M.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (12) : 1402 - 1406
12345